A confluence of market factors influencing the dynamics and growth trajectory of the Small Animal Imaging Market shapes it. Heightened attention to personalized medicine and targeted therapies has increased the importance of small animal imaging in drug development and research. As shown by their reliance on these imaging modalities to evaluate new drugs’ efficacy and safety, researchers, and pharmaceutical companies have contributed to increased market demand. This suggests that molecular biology, genetics, and invasive but precise methods like small animal imaging are essential tools for understanding disease mechanisms.
The Small Animal Imaging Market is shaped by technology advancements. Development of modern imaging modalities such as positron emission tomography (PET), single-photon emission computed tomography (SPECT), magnetic resonance imaging (MRI) and computed tomography (CT) have improved image quality. This not only added value in terms of the quality of data but also made it more cost-effective hence driving market expansion.
Further still, a sprawling adoption within academic and research institutions using small animal imaging has fueled market growth. The versatility of this technology along with its ability to enable real-time, in vivo images has made it indispensable in academic study into multiple diseases models. Additionally, many contract research organizations (CROs) offering preclinical imaging services have expanded the market’s scope while providing cost-effective means through which pharmaceutical as well as biotechnology firms could access this kind of services.
Factors such as budget allocation or cost constraints within the healthcare or research sectors affect the Small Animal Imaging Market from an economic point of view. The decision to purchase rests on how affordable equipment is including maintenance costs plus all other operational expenses associated with it. For this reason, market players continuously endeavor at developing inexpensive but high-quality imaging solutions thus addressing buyers’ economical considerations.”
Small Animal Imaging Market Overview
The Small Animal Imaging Market size is expected to reach USD 14.9 Billion by 2032 at 6.2% CAGR during the forecast period 2023-2032. Small animal imaging is a technique that uses imaging equipment and reagents to monitor molecular or cellular processes in animals such as rats and mice for drug development and gene expression research.
However, regulatory rules governing the use of animals in investigations, as well as the expensive cost of equipment, may limit the expansion of the small animal imaging industry. The growing need for non-invasive small animal imaging techniques, as well as technical breakthroughs in the sector, is propelling the market forward. Furthermore, major market players are concentrating on launching new products on a regular basis, which is expected to contribute to market growth.
Research Methodology
Market Research Future research is conducted by industry experts who offer insight into industry structure, market segmentation, Treatment assessment, competitive landscape (CL), penetration, as well as on emerging trends. Besides primary interviews (~ 80%) and secondary research (~ 20%), their analysis is based on their years of professional expertise in respective industries. Our analysts also predict where the market will be headed in the next five to ten years, by analyzing historical trends and current market positions. Furthermore, the varying trends of segments & categories geographically presented are studied and are estimated based on primary & secondary research.
The extensive primary research was conducted to gain a deeper insight into the market and the industry performance. In this particular report, we have conducted primary surveys (interviews) with the key level executives (VP, CEO's, Marketing Director, Business Development Manager and many more) of the major players who are active in the market. In addition to analyzing the current and historical trends, our analysts predict where the market is headed, over the next five to ten years.
Secondary research was mainly used to collect and identify information useful for an extensive, technical, market-oriented, and commercial study of the small animal imaging market. It was also used to obtain key information about major players, market classification and segmentation according to the industry trends, geographical markets, & developments related to the market and Treatment Perspectives. For this study, analysts have gathered information from various credible sources, such as annual reports, SEC filings, journals, white papers, corporate presentations, company websites, the international organization of chemical manufacturers, some paid databases and many others.
Segmentation
The small animal imaging market is segmented on the basis of the modality and reagents.
On the basis of the modality, the market is classified into optical imaging systems, nuclear imaging systems, micro-MRI systems, micro-ultrasound systems, micro-CT systems, photoacoustic imaging systems, and Magnetic Particle Imaging (MPI) systems. The optical imaging systems are further segmented into bioluminescence/ fluorescence imaging systems, standalone fluorescence imaging systems, and optical + X-Ray/optical + CT systems. The nuclear imaging systems are segmented into micro-Pet systems, micro-spect systems, and trimodality (spect/pet/CT) systems. The micro-pet system is further segmented into standalone pet systems, pet/CT system, and pet/MRI systems. The micro-spect system is further segmented into standalone spect systems, spect/CT system, and spect/MRI systems.
On the basis of reagent, the market is segmented as optical imaging reagents, nuclear imaging reagents, MRI contrast agents, ultrasound contrast agents, and CT contrast agents. The optical imaging reagents are further segmented as bioluminescent imaging reagents and fluorescent imaging reagents. The bioluminescent imaging reagents are further segmented into luciferins, pro-luciferins, coelenterazine, and other bioluminescent imaging reagents. The fluorescent imaging reagents are further segmented as green fluorescent proteins, red fluorescent proteins, infrared dyes, other fluorescent imaging reagents. The nuclear imaging reagents are segmented into pet tracers and spect probes. The pet tracers are further classified into fluorine-18-based small animal pet tracers, carbon-11-based small animal pet tracers, copper-64-based small animal pet tracers, and other spect probes. The spect probes are further segmented into technetium-99m-based small animal spect probes, iodine-131-based small animal spect probes, gallium-67-based small animal spect probes, thallium-201-based small animal spect probes, and other spect probes. The MRI contrast agents are segmented into gadolinium-based small animal contrast agents, iron-based small animal contrast agents, and manganese-based small animal contrast agents. The CT contrast agents are further segmented into iodine-based small animal CT contrast agents, barium-based small animal CT contrast agents, gold nanoparticles and gastrografin-based small animal CT contrast media.
Geographically, the market has been segmented into America, Europe, Asia Pacific, and the Middle East & Africa. The Americas small animal imaging market is further segmented into North America, and South America. North America is further classified as U.S. and Canada.
The Europe small animal imaging market is segmented into Western Europe and Eastern Europe. Western Europe is further classified as Germany, France, U.K., Italy, Spain, and the Rest of Western Europe.
The Asia Pacific small animal imaging market is segmented into Japan, China, India, Republic of Korea, Australia, and the Rest of Asia Pacific.
The Middle East & Africa small animal imaging market is segmented into the Middle East and Africa.
Regional Market Summary
The Americas is likely to dominate the global small animal imaging market owing to investments by clinical research organizations in pre-clinical studies, increasing government funding in research activities and increasing number of pharmaceutical and research-based organizations. For instance, the National Institute of Health (NIH) received 1 Billion USD, in the year 2015 for life science and health-related research and development programs. Moreover, the presence of leading market players such as PerkinElmer Inc., Bruker Corporation, Trifoil Imaging, and LI-COR Biosciences within the region contributes to the market growth.
Europe is expected to hold the second position in the global small animal imaging market. The market growth is attributed to rising R&D investments by pharmaceutical companies and growing number of research organizations for diagnosis of diseases. For instance, the European Commission stated that the R&D spending by pharmaceuticals and biotechnology sector grew by 8.7% in 2021.
The Asia Pacific is the fastest growing region in global small animal imaging market. The developing countries such as China and India are offering high growth opportunities for the small animal imaging market players. Moreover, increasing government support for biotechnology and pharmaceutical R&D and growing number of translational research activities contributes to the market growth.
The Middle East & Africa holds the lowest share of the global small animal imaging market due to low development in the healthcare sector, lack of technical knowledge, and poor medical facilities.
Key Players
Some of the key players in the global small animal imaging market are PerkinElmer Inc. (U.S.) Bruker Corporation (U.S.), FUJIFILM Holdings Corporation (Japan), Mediso Ltd. (Hungary), MILabs B.V. (Netherlands), MR Solutions Ltd. (U.K.), Aspect Imaging (Israel), LI-COR Biosciences (U.S.), Trifoil Imaging (U.S.) and Miltenyi Biotec GmbH (Germany).
Small Animal Imaging Market, by Modality
Small Animal Imaging Market, by Reagents
Small Animal Imaging Market, by Region
Company Profiles
Recent Development
PerkinElmer, Inc., formerly Perkin-Elmer, is an American multinational organization that specializes in diagnostics, life science research, food, environmental, and industrial testing. For a variety of end markets, PerkinElmer manufactures analytical equipment, genetic testing, and diagnostic tools, medical imaging components, software, devices, and consumables. PerkinElmer is an S & P 500 company with operations in 190 countries.
Molecular biology, chemistry, computer science, engineering, and medicine are all involved in molecular imaging. Optical imaging (either by bioluminescence or fluorescence), computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single-photon emission computed tomography (SPECT), and ultrasound have all been used to monitor structural, functional, and molecular changes in cancer tissues (US). In 2021, the company said, the worldwide molecular imaging market is predicted to be worth the US $4,309.0 million, growing at a CAGR of 5.4 percent over the forecast period (2021–2028).Intended Audience
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)